Fulcrum Therapeutics – Patient Worthy

source: pixabay.com

ICYMI Fulcrum Therapeutic’s Sickle Cell Disease Treatment On Track for a New Drug Application

Post author:Sunniva Bean
Post published:April 27, 2020
Post category:Muscular Dystrophy

As reported in Biospace, Fulcrum Therapeutics has announced it will be submitting an application to the FDA for FTX-6058 as an Investigational New Drug (IND) by the end of 2020…

CLICK HERE TO SHARE YOUR STORY!

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More